User login
As politics and politicians enhance divisiveness in our country, science and scientists will save us. The power of collective science, careful data analysis, and cautious interpretation has never been more evident than during this pandemic. Unfortunately, we still are learning the most effective means of communicating scientific knowledge where development is iterative and rarely definitive in the early stages of hypothesis testing. Once again, we see the destructive power and effectiveness of the techniques detailed in The Merchants of Doubt.
I choose to focus on successes of scientists and our care delivery workforce. In a mere 11 months, researchers created a new vaccine methodology, tested its safety and efficacy against COVID-19, and provided it to experts building the logistic infrastructure to vaccinate billions of people. Simultaneously, thousands of health care workers risked their lives in a daily battle against Coronavirus and saved countless lives. This is why we became scientists and providers.
I had difficulty choosing page one articles this month because of the wealth of material. On page one, we read about the most dramatic changes to Medicare E/M documentation in the last 30 years (resulting in an estimated 4% decrease in overall GI reimbursements). Another article reports on real reductions in liver-related deaths in states that expanded Medicaid coverage, once again demonstrating that we save lives if people have access to health care. The third article on page one discusses seronegative enteropathy – a difficult diagnosis but one with emerging answers.
Elsewhere in GI and Hepatology News, read about best practices to care for elderly IBD patients, EUS interventional advances, and interesting information that may lead to more targeted obesity therapies.
Articles highlighted above and others in this month’s issue show us that scientific inquiry, research and solution-finding is alive and well.
“The good thing about science is that it’s true whether or not you believe in it.” -- Neil deGrasse Tyson
John I. Allen, MD, MBA, AGAF
Editor in Chief
As politics and politicians enhance divisiveness in our country, science and scientists will save us. The power of collective science, careful data analysis, and cautious interpretation has never been more evident than during this pandemic. Unfortunately, we still are learning the most effective means of communicating scientific knowledge where development is iterative and rarely definitive in the early stages of hypothesis testing. Once again, we see the destructive power and effectiveness of the techniques detailed in The Merchants of Doubt.
I choose to focus on successes of scientists and our care delivery workforce. In a mere 11 months, researchers created a new vaccine methodology, tested its safety and efficacy against COVID-19, and provided it to experts building the logistic infrastructure to vaccinate billions of people. Simultaneously, thousands of health care workers risked their lives in a daily battle against Coronavirus and saved countless lives. This is why we became scientists and providers.
I had difficulty choosing page one articles this month because of the wealth of material. On page one, we read about the most dramatic changes to Medicare E/M documentation in the last 30 years (resulting in an estimated 4% decrease in overall GI reimbursements). Another article reports on real reductions in liver-related deaths in states that expanded Medicaid coverage, once again demonstrating that we save lives if people have access to health care. The third article on page one discusses seronegative enteropathy – a difficult diagnosis but one with emerging answers.
Elsewhere in GI and Hepatology News, read about best practices to care for elderly IBD patients, EUS interventional advances, and interesting information that may lead to more targeted obesity therapies.
Articles highlighted above and others in this month’s issue show us that scientific inquiry, research and solution-finding is alive and well.
“The good thing about science is that it’s true whether or not you believe in it.” -- Neil deGrasse Tyson
John I. Allen, MD, MBA, AGAF
Editor in Chief
As politics and politicians enhance divisiveness in our country, science and scientists will save us. The power of collective science, careful data analysis, and cautious interpretation has never been more evident than during this pandemic. Unfortunately, we still are learning the most effective means of communicating scientific knowledge where development is iterative and rarely definitive in the early stages of hypothesis testing. Once again, we see the destructive power and effectiveness of the techniques detailed in The Merchants of Doubt.
I choose to focus on successes of scientists and our care delivery workforce. In a mere 11 months, researchers created a new vaccine methodology, tested its safety and efficacy against COVID-19, and provided it to experts building the logistic infrastructure to vaccinate billions of people. Simultaneously, thousands of health care workers risked their lives in a daily battle against Coronavirus and saved countless lives. This is why we became scientists and providers.
I had difficulty choosing page one articles this month because of the wealth of material. On page one, we read about the most dramatic changes to Medicare E/M documentation in the last 30 years (resulting in an estimated 4% decrease in overall GI reimbursements). Another article reports on real reductions in liver-related deaths in states that expanded Medicaid coverage, once again demonstrating that we save lives if people have access to health care. The third article on page one discusses seronegative enteropathy – a difficult diagnosis but one with emerging answers.
Elsewhere in GI and Hepatology News, read about best practices to care for elderly IBD patients, EUS interventional advances, and interesting information that may lead to more targeted obesity therapies.
Articles highlighted above and others in this month’s issue show us that scientific inquiry, research and solution-finding is alive and well.
“The good thing about science is that it’s true whether or not you believe in it.” -- Neil deGrasse Tyson
John I. Allen, MD, MBA, AGAF
Editor in Chief